Recruiting
Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma
NCT04961515
- Conditions
- Primary Central Nervous System Hodgkin Lymphoma
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China